These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33506985)

  • 1. New psychoactives within polydrug use trajectories-evidence from a mixed-method longitudinal study.
    Higgins K; O'Neill N; O'Hara L; Jordan JA; McCann M; O'Neill T; Clarke M; O'Neill T; Kelly G; Campbell A
    Addiction; 2021 Sep; 116(9):2454-2462. PubMed ID: 33506985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Belfast Youth Development Study (BYDS): A prospective cohort study of the initiation, persistence and desistance of substance use from adolescence to adulthood in Northern Ireland.
    Higgins K; McLaughlin A; Perra O; McCartan C; McCann M; Percy A; Jordan JA
    PLoS One; 2018; 13(5):e0195192. PubMed ID: 29791433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
    Champion KE; Teesson M; Newton NC
    Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typology of new psychoactive substance use among the general Australian population.
    Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
    Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilevel population-based cross-sectional study examining school substance-misuse policy and the use of cannabis, mephedrone and novel psychoactive substances among students aged 11-16 years in schools in Wales.
    Midgley LS; Murphy S; Moore G; Hewitt G; White J
    BMJ Open; 2018 Jun; 8(6):e020737. PubMed ID: 29903791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion.
    Kelly AB; Evans-Whipp TJ; Smith R; Chan GC; Toumbourou JW; Patton GC; Hemphill SA; Hall WD; Catalano RF
    Addiction; 2015 Apr; 110(4):627-35. PubMed ID: 25510264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years.
    Chan G; Connor J; Hall W; Leung J
    Addiction; 2020 Jan; 115(1):145-155. PubMed ID: 31357251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
    Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
    Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
    Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
    J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-course trajectories of cannabis use: a latent class analysis of a New Zealand birth cohort.
    Boden JM; Dhakal B; Foulds JA; Horwood LJ
    Addiction; 2020 Feb; 115(2):279-290. PubMed ID: 31503369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
    Rychert M; Wilkins C; Parker K; Witten K
    Drug Alcohol Rev; 2018 Mar; 37(3):406-413. PubMed ID: 29285812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent Classes of Substance Use in Young Adults - A Systematic Review.
    de Jonge MC; Bukman AJ; van Leeuwen L; Onrust SA; Kleinjan M
    Subst Use Misuse; 2022; 57(5):769-785. PubMed ID: 35188870
    [No Abstract]   [Full Text] [Related]  

  • 15. Ecstasy and new patterns of drug use: a normal population study.
    Pedersen W; Skrondal A
    Addiction; 1999 Nov; 94(11):1695-706. PubMed ID: 10892008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
    Scherbaum N; Schifano F; Bonnet U
    Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of psychoactive substances among adolescent students in an area in the south-west of China.
    Liu Z; Zhou W; Lian Z; Mu Y; Cai Z; Cao J
    Addiction; 2001 Feb; 96(2):247-50. PubMed ID: 11182869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typologies of illicit drug use in mid-adulthood: a quasi-longitudinal latent class analysis in a community-based sample of twins.
    Dash GF; Martin NG; Agrawal A; Lynskey MT; Slutske WS
    Addiction; 2021 May; 116(5):1101-1112. PubMed ID: 33463859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M; Wilkins C
    Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.